1,069 results on '"Aaronson, Stuart A"'
Search Results
152. Human Cell Strains Susceptible to Focus Formation by Human Adenovirus Type 12
153. Cell Culture Techniques in the Search for Cancer Viruses of Man
154. Abstract 41: Tumor resistance to CDK4/6 inhibitors and degraders determined by the expression state of CDK6
155. Abstract 78: A strategy for effective targeting of oncogenic BRAF signaling with increased therapeutic index using conformation-selective RAF and MEK inhibitors
156. Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging
157. Brachyury: A New Player in Promoting Breast Cancer Aggressiveness
158. CDIP, a novel pro‐apoptotic gene, regulates TNFα‐mediated apoptosis in a p53‐dependent manner
159. Hzf Determines Cell Survival upon Genotoxic Stress by Modulating p53 Transactivation
160. Rewired ERK-JNK Signaling Pathways in Melanoma
161. Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling
162. p53 induction and activation of DDR1 kinase counteract p53‐mediated apoptosis and influence p53 regulation through a positive feedback loop
163. Inhibition of p21‐mediated ROS accumulation can rescue p21‐induced senescence
164. Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response
165. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53
166. Oncogenes and Signal Transduction
167. List of Contributing Authors
168. Withdrawal: DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation.
169. Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts
170. A novel human ERK phosphatase regulates H-ras and v-raf signal transduction
171. Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas
172. 292 p53 Transcriptionally activates IRF9 to enhance antiviral immunity
173. The BRCA2 gene product functionally interacts with p53 and RAD51
174. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
175. High-Frequency C-Type Virus Induction by Inhibitors of Protein Synthesis
176. Bovine Lymphosarcoma: Development of a Radioimmunologic Technique for Detection of the Etiologic Agent
177. In vivo Identification of the Transforming Gene Product of Simian Sarcoma Virus
178. Continuous Lines of Basophil/Mast Cells Derived from Normal Mouse Bone Marrow
179. Identification of the Hepatocyte Growth Factor Receptor as the c-met Proto-Oncogene Product
180. Simian Sarcoma Virus onc Gene, v-sis, is Derived from the Gene (or Genes) Encoding a Platelet-Derived Growth Factor
181. Normal Cells of Patients with High Cancer Risk Syndromes Lack Transforming Activity in the NIH/3T3 Transfection Assay
182. Neoplastic Transformation of Human Epidermal Keratinocytes by AD12-SV40 and Kirsten Sarcoma Viruses
183. Amplification of a Novel v-erbB-Related Gene in a Human Mammary Carcinoma
184. A human oncogene of the RAS superfamily unmasked by expression cDNA cloning
185. Basis for the Acquisition of Malignant Potential by Mouse Cells Cultivated in vitro
186. Heterogeneity of Murine Leukemia Virus in vitro DNA; Detection of Viral DNA in Mammalian Cells
187. Induction of Murine C-Type Viruses from Clonal Lines of Virus-Free BALB/3T3 Cells
188. Susceptibility of Cells from Patients with Primary Immunodeficiency Diseases to Transformation by Simian Virus 40
189. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains
190. Platelet-derived growth factor AB heterodimer interchain interactions influence secretion as well as receptor binding and activation
191. Identification of a competitive HGF antagonist encoded by an alternative transcript
192. Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product
193. Comparative Analysis of p73 and p53 Regulation and Effector Functions
194. Molecular localization of the transforming and secretory properties of PDGF A and PDGF B
195. EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling
196. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
197. Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade
198. Abstract LB-119: SHP2 drives adaptive resistance to ERK signaling inhibition in molecularly defined subsets of ERK-dependent tumors
199. Retraction Notice to: RhoE Is a Pro-Survival p53 Target Gene that Inhibits ROCK I-Mediated Apoptosis in Response to Genotoxic Stress
200. Expression of Concern for Lee et al., “Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.